More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis ; volume:14 ; number:9 ; day:7 ; month:8 ; year:2024 ; pages:2621-2630 ; date:9.2024
Dermatology and therapy ; 14, Heft 9 (7.8.2024), 2621-2630, 9.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Blauvelt, Andrew
Eyerich, Kilian
Irvine, Alan D.
Bruin-Weller, Marjolein de
Kwatra, Shawn G.
Gooderham, Melinda
Kim, Brian
Calimlim, Brian M.
Lee, Wan-Ju
Raymundo, Eliza M.
Liu, Yingyi
Ofori, Sarah
Platt, Andrew M.
Silverberg, Jonathan I.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-024-01242-9
- URN
-
urn:nbn:de:101:1-2411262119234.875989012621
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blauvelt, Andrew
- Eyerich, Kilian
- Irvine, Alan D.
- Bruin-Weller, Marjolein de
- Kwatra, Shawn G.
- Gooderham, Melinda
- Kim, Brian
- Calimlim, Brian M.
- Lee, Wan-Ju
- Raymundo, Eliza M.
- Liu, Yingyi
- Ofori, Sarah
- Platt, Andrew M.
- Silverberg, Jonathan I.
- SpringerLink (Online service)
Other Objects (12)
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Dupilumab bei Patienten mit atopischem Ekzem in der klinischen Praxis
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals
Prä- und Postkonditionierung von ischämischem Haut- und Muskelgewebe mit Erythropoetin
Advancements in bullous pemphigoid treatment: a comprehensive pipeline update
Die Bedeutung der miRNA-221 und -222 für die Puma vermittelte Apoptose in Schleimhautmelanomen und kutanen Melanomen
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
Mapping of Disease Severity in Patients with Systemic Sclerosis
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses
Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV‐Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Dupilumab bei Patienten mit atopischem Ekzem in der klinischen Praxis
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals
Prä- und Postkonditionierung von ischämischem Haut- und Muskelgewebe mit Erythropoetin
Advancements in bullous pemphigoid treatment: a comprehensive pipeline update
Die Bedeutung der miRNA-221 und -222 für die Puma vermittelte Apoptose in Schleimhautmelanomen und kutanen Melanomen
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
Mapping of Disease Severity in Patients with Systemic Sclerosis
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses
Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV‐Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen
More time spent with clear skin and no itch with upadacitinib versus dupilumab for atopic dermatitis
Aggregate response benefit in skin clearance and itch reduction with upadacitinib or dupilumab in patients with moderate-to-severe atopic dermatitis
Dupilumab bei Patienten mit atopischem Ekzem in der klinischen Praxis
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals
Prä- und Postkonditionierung von ischämischem Haut- und Muskelgewebe mit Erythropoetin
Advancements in bullous pemphigoid treatment: a comprehensive pipeline update
Die Bedeutung der miRNA-221 und -222 für die Puma vermittelte Apoptose in Schleimhautmelanomen und kutanen Melanomen
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
Mapping of Disease Severity in Patients with Systemic Sclerosis
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses